Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Acta Clinica Belgica|March 18, 2020
Nivolumab and anti-HCV activity, a case reportLaura Wuyts, Annelies Janssens, Luisa Vonghia, et al.
Cancers|April 30, 2021
Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy-The Role of Liquid Biopsy in Unraveling the PuzzleElien Augustus, Karen Zwaenepoel, Vasiliki Siozopoulou, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Recurrent dysphasia due to nivolumab-induced encephalopathy with presence of Hu autoantibodyJo Raskin, Pegah Masrori, Antonin Cant, et al.
Cancers|April 8, 2020
Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC PatientsEline Berghmans, Julie Jacobs, Christophe Deben, et al.
Cancers|July 27, 2022
New Implications of Patients' Sex in Today's Lung Cancer ManagementJo Raskin, Annemiek Snoeckx, Annelies Janssens, et al.
Lung Cancer (Amsterdam, Netherlands)|January 23, 2021
Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 monthsPegah Masrori, Hannah Vaesen Bentein, Jo Raskin, et al.
Cancers|July 9, 2022
External Validation of a Breath-Based Prediction Model for Malignant Pleural MesotheliomaEline Janssens, Eline Schillebeeckx, Kathleen Zwijsen, et al.
Future Oncology (London, England)|March 31, 2023
Plain language summary of the development of tepotinib: a treatment for a subtype of non-small cell lung cancer called MET exon 14 skippingJohn Hallick, Anne-Marie Baird, Gerald Falchook, et al.
Plos One|April 7, 2020
The art of obtaining a high yield of cell-free DNA from urineElien Augustus, Kaat Van Casteren, Laure Sorber, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2026
Multi-omic screening for pleural mesothelioma in Asbestos-Exposed Populations: A literature review and RecommendationsKathleen Zwijsen, Ellen Heirwegh, Eline Schillebeeckx, et al.
Pageof 4